News
-PLX-61639, a selective, oral SMARCA2 degrader, demonstrated sustained PD response and single-agent efficacy in SMARCA4 mutant tumors; program is advancing through IND-enabling studies- -PLX-4545 ...
21 followers Cambridge, UK https://www.zoo.cam.ac.uk/research/groups/connectomics [email protected] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback